Mutation-Driven Remodeling of the LRRK2 Kinase Free-Energy Landscape and Its Consequences for Conformational

Rajesh Ghosh1, Kousik K Bhanja1, Niladri Patra1

  • 1Department of chemistry & Chemical Biology, Indian Institute of Technology (ISM) Dhanbad, Dhanbad, Jharkhand 826004, India.

Insights

Mutations in LRRK2 (leucine-rich repeat kinase 2) are linked to Parkinson's disease. This study reveals how the G2019S mutation stabilizes the active kinase form, offering insights into disease mechanisms and drug development.

Area of Science:

  • Biochemistry and Molecular Biology
  • Neurodegenerative Diseases
  • Structural Biology

Background:

  • Parkinson's disease (PD) is a common neurodegenerative disorder linked to LRRK2 gene mutations.
  • While wild-type (WT) LRRK2 structures are known, the transition states and mutant dynamics remain unclear.
  • Understanding these dynamics is crucial for elucidating PD pathogenesis and developing targeted therapies.

Purpose of the Study:

  • To elucidate how LRRK2 mutations, specifically G2019S, alter conformational dynamics.
  • To identify intermediate conformational states (INTs) in LRRK2 activation and inactivation pathways.
  • To investigate the impact of the G2019S mutation on kinase activity and inhibitor binding.

Main Methods:

  • Molecular dynamics (MD) simulations to analyze conformational changes.
  • Two-dimensional Well-Tempered Metadynamics (2D WT-MetaD) to map free-energy landscapes.
  • Assessment of type-I inhibitor LRRK2-IN-1 binding affinity using absolute binding free-energy calculations.
  • Two-dimensional Umbrella Sampling (2D-US) to study apo-state transitions.

Main Results:

  • The G2019S mutation lowers the energy barrier for LRRK2 activation, favoring a hyperactive state.
  • The mutant active state is more stable than WT, requiring more energy to transition back to inactivation.
  • The type-I inhibitor LRRK2-IN-1 preferentially stabilizes the G2019S mutant active conformation.
  • Specific salt bridges and activation loop dynamics were identified as key regulators of LRRK2 states.

Conclusions:

  • The G2019S mutation facilitates sustained LRRK2 activation, explaining its kinase hyperactivity in PD.
  • This study provides a mechanistic basis for the G2019S mutation's role in Parkinson's disease.
  • Findings support the development of inhibitors that target the stabilized active conformation of mutant LRRK2.

Related Concept Videos

Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Allosteric Regulation01:08

Allosteric Regulation

Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.